Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice
The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
We recently reported that mice deficient in the programmed cell death-1 (PD-1) immunoinhibitory coreceptor develop autoimmune dilated cardiomyopathy (DCM), with production of high-titer autoantibodies against a heart-specific, 30-kDa protein. In this study, we purified the 30-kDa protein from heart extract and identified it as cardiac troponin I (cTnI), encoded by a gene in which mutations can cause familial hypertrophic cardiomyopathy (HCM). Administration of monoclonal antibodies to cTnI induced dilatation and dysfunction of hearts in wild-type mice. Monoclonal antibodies to cTnI stained the surface of cardiomyocytes and augmented the voltage-dependent L-type Ca2+ current of normal cardiomyocytes. These findings suggest that antibodies to cTnI induce heart dysfunction and dilatation by chronic stimulation of Ca2+ influx in cardiomyocytes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the cardiotoxicity of anti-cTnI autoantibodies has been reported in studies using BALB/c mice lacking PD-1 expression”
From Autoimmune Myocarditis, Old Dogs and New Tricks. (2024) · cites this paper as [97]
In the citing paper
“PD-1-deficient BALB/c mice spontaneously developed autoimmune DCM mediated by anti-cTnI antibodies, and the pathology was transferable when wild-type mice were treated with these autoantibodies”
From Autoimmune Myocarditis, Old Dogs and New Tricks. (2024) · cites this paper as [97]
In the citing paper
“suggesting a potential mechanism of ICI myocarditis.”
From Autoimmune Myocarditis, Old Dogs and New Tricks. (2024) · cites this paper as [97]
In the citing paper
“the cardiotoxicity of anti-cTnI antibodies has been reported in PD-1 -/- BALB/c mice”
From Autoimmune Myocarditis, Old Dogs and New Tricks. (2024) · cites this paper as [97]
In the citing paper
“However, these autoantibodies are generally not disease-specific and may not consistently induce the disease phenotype in murine models, indicating their limitations as diagnostic and therapeutic targets. 57,92,97,191”
From Autoimmune Myocarditis, Old Dogs and New Tricks. (2024) · cites this paper as [97]
Citations
Cites
Hamill, O. P., Marty, A., Neher, E., Sakmann, B., & Sigworth, F. J. (1981) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/bf00656997 · Cited by 18,436
A Calcineurin-Dependent Transcriptional Pathway for Cardiac Hypertrophy
Molkentin, J. D., Lu, J.-R., Antos, C. L., Markham, B., Richardson, J., Robbins, J., Grant, S. R., & Olson, E. N. (1998) · Cell · doi:10.1016/s0092-8674(00)81573-1 · Cited by 2,566
Autoimmune Dilated Cardiomyopathy in PD-1 Receptor-Deficient Mice
Nishimura, H., Okazaki, T., Tanaka, Y., Nakatani, K., Hara, M., Matsumori, A., Sasayama, S., Mizoguchi, A., Hiai, H., Minato, N., et al. (2001) · Science · doi:10.1126/science.291.5502.319 · Cited by 1,868
Self-citationThe Genetic Basis for Cardiomyopathy
Seidman, J. G., & Seidman, C. (2001) · Cell · doi:10.1016/s0092-8674(01)00242-2 · Cited by 1,046
Calcium tolerant ventricular myocytes prepared by preincubation in a ?KB medium?
Isenberg, G., & Klockner, U. (1982) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/bf00584963 · Cited by 898
Mutations in Sarcomere Protein Genes as a Cause of Dilated Cardiomyopathy
Kamisago, M., Sharma, S. D., DePalma, S. R., Solomon, S., Sharma, P., McDonough, B., Smoot, L., Mullen, M. P., Woolf, P. K., Wigle, E. D., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012073432304 · Cited by 720
Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy
Kimura, A., Harada, H., Park, J.-E., Nishi, H., Satoh, M., Takahashi, M., Hiroi, S., Sasaoka, T., Ohbuchi, N., Nakamura, T., et al. (1997) · Nature Genetics · doi:10.1038/ng0897-379 · Cited by 577
Cardiac myosin induces myocarditis in genetically predisposed mice.
Neu, N., Rose, N. R., Beisel, K. W., Herskowitz, A., Gurri-Glass, G., & Craig, S. W. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.11.3630 · Cited by 526
Cardiac defects and altered ryanodine receptor function in mice lacking FKBP12
Shou, W., Aghdasi, B., Armstrong, D. L., Guo, Q., Bao, S., Charng, M.-J., Mathews, L. M., Schneider, M. D., Hamilton, S. L., & Matzuk, M. M. (1998) · Nature · doi:10.1038/35146 · Cited by 431
Cited by
Items 501–600 of 688
Yin, N., Liu, X., Ye, X., Song, W., Lu, J., & Chen, X. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.961266 · Cited by 8
Nishimura, T., Ninomiya, K., Nakashima, M., Akagi, S., Kuribayashi, T., Higo, H., Hotta, K., Maeda, Y., Ito, H., & Kiura, K. (2022) · Internal Medicine · doi:10.2169/internalmedicine.0505-22 · Cited by 9
Cardiovascular Immunotoxicity Associated with Immune Checkpoint Inhibitors in Metastatic Melanoma
L'Orphelin, J. ‐., Dollalille, C., Akroun, J., Alexandre, J., & Dompmartin, A. (2023) · Cancers · doi:10.3390/cancers15072170 · Cited by 7
Dibos, M., Dumoulin, J., Mogler, C., Wunderlich, S., Reichert, M., Rasch, S., Schmid, R. M., Ringelhan, M., Ehmer, U., & Lahmer, T. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12144641 · Cited by 7
Marco, A. D., Artioli, G., Favaretto, A. G., Cavasin, N., & Basso, U. (2024) · Medicine · doi:10.1097/md.0000000000037606 · Cited by 7
Novedades en inmunología del melanoma
Escandell, I., Martín, J. M., & Jordá, E. (2017) · Actas Dermo-Sifiliográficas · doi:10.1016/j.ad.2017.01.017 · Cited by 7
Kuzuya, K., Ichihara, S., Suzuki, Y., Inoue, C., Ichihara, G., Kurimoto, S., & Oikawa, S. (2018) · PLoS ONE · doi:10.1371/journal.pone.0192624 · Cited by 7
The Price of Success: Immune-Related Adverse Events from Immunotherapy in Lung Cancer
Coschi, C. H., & Juergens, R. A. (2021) · Current Oncology · doi:10.3390/curroncol28060373 · Cited by 7
Lessons learned from experimental myocarditis
Matsumori, A. (2012) · Herz · doi:10.1007/s00059-012-3692-z · Cited by 7
Self-citationA novel humanized anti-PD-1 monoclonal antibody potentiates therapy in oral squamous cell carcinoma
Cai, Y., Wang, F., Liu, Q., Li, Z., Li, D., & Sun, Z. (2018) · Investigational New Drugs · doi:10.1007/s10637-018-0678-6 · Cited by 7
Effect of SARS-CoV-2 mRNA-Vaccine on the Induction of Myocarditis in Different Murine Animal Models
Zirkenbach, V. A., Ignatz, R. M., Öttl, R., Cehreli, Z., Stroikova, V., Kaya, M., Lehmann, L., Preusch, M. R., Frey, N., & Kaya, Z. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24055011 · Cited by 7
Immunadsorption als Therapieverfahren der dilatativen Kardiomyopathie
Felix, S. B., Dörr, M., Herda, L. R., Beug, D., & Staudt, A. (2007) · Der Internist · doi:10.1007/s00108-007-1991-x · Cited by 6
Myocardial Dysfunction in Patients with Cancer
Koutroumpakis, E., Agrawal, N., Palaskas, N. L., Abe, J., Iliescu, C., Yusuf, S. W., & Deswal, A. M. (2022) · Heart Failure Clinics · doi:10.1016/j.hfc.2022.02.011 · Cited by 6
Cardiotoxicity mechanisms of antitumor therapy with immune checkpoint inhibitors: new achievements
Khidirova, L. D., Latsvieva, A. E., & Vederin, A. V. (2024) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2024-3022 · Cited by 6
Gatselis, N., Azariadis, K., Lyberopoulou, A., & Dalekos, G. N. (2021) · Journal of Translational Autoimmunity · doi:10.1016/j.jtauto.2021.100126 · Cited by 6
Nivolumab-induced pneumonitis and cardiopathy in a patient with relapsed Hodgkin's lymphoma
Bonhomme‐Faivre, L., Guarino, V., & Misra, S. C. (2022) · Journal of Oncology Pharmacy Practice · doi:10.1177/10781552221105572 · Cited by 7
Dülgar, Ö., Saha, A., Elleson, K. M., & Markowitz, J. (2023) · Immunotherapy · doi:10.2217/imt-2022-0213 · Cited by 7
Peripheral B lymphocyte tolerance
Gavin, A. L., Aït‐Azzouzene, D., Mårtensson, A., Duong, B. H., Verkoczy, L. K., Skog, J., Skog, P. D., & Nemazee, D. A. (2004) · The Keio Journal of Medicine · doi:10.2302/kjm.53.151 · Cited by 8
Lappé, J. M., Pelfrey, C. M., Cotleur, A. C., & Tang, W. H. W. (2011) · Clinical and Translational Science · doi:10.1111/j.1752-8062.2011.00313.x · Cited by 9
Polymorphisms in PDCD1 gene are not associated with aplastic anemia in Chinese Han population
Ming, Z. J., Hui, H., Miao, M., Qiu, Y., & Zhang, X. (2011) · Rheumatology International · doi:10.1007/s00296-011-2127-0 · Cited by 6
Lack of evidence for a pathogenic role of proteasome-directed autoimmunity in dilated cardiomyopathy
Beling, A., Trimpert, C., Bartel, K., Egerer, K., Kuckelkorn, U., Feist, E., Gericke, C., Klingel, K., Kandolf, R., Felix, S. B., et al. (2010) · Basic Research in Cardiology · doi:10.1007/s00395-010-0096-1 · Cited by 6
Escape Strategies of Tumors from Immune Surveillence
Šťastný, M. (2015) · Klinicka onkologie · doi:10.14735/amko20154s28 · Cited by 6
Abdelkrim, M. A., Mallem, Y., Chatagnon, G., Gogny, M., Desfontis, J., & Noireaud, J. (2012) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y2012-006 · Cited by 6
Carpal Tunnel Syndrome Associated with Immune Checkpoint Inhibitors
Yakobson, A., Rouvinov, K., Cohen, A. Y., Goldstein, I. M., Saleh, O. A., Solomon, A., Dudnik, Y., & Shalata, W. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13091340 · Cited by 6
Mucosal tolerance induction in autoimmune myocarditis and myocardial infarction
Li, J., Göser, S., Leuschner, F., Volz, H. C., Buss, S. J., Andrassy, M., Öttl, R., Pfitzer, G., Katus, H. A., & Kaya, Z. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.05.057 · Cited by 6
Moreno, S. F. L., Lenz, S. A., Casso-Chapa, B., Paniagua-Bojorges, A., Kim, J. H., Palaskas, N. L., Nead, K. T., Samanthapudi, V. S. K., Mejia, G. F., Hoang, O. N., et al. (2025) · Antioxidants · doi:10.3390/antiox14121388 · Cited by 7
Chen, Y., Wang, X., Shen, Y., Zhang, H., Yu, C., Cheng, L., & Ge, J. (2025) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2025.12.004 · Cited by 5
Cardiac Troponin I and Risk of Stroke: A Mendelian Randomization Study
Chen, H., Sun, X., Zhuo, C., Zhao, J., Zu, A., Wang, Q., & Zheng, L. (2022) · International Journal of General Medicine · doi:10.2147/ijgm.s351034 · Cited by 5
Clinical characteristics, treatment and prognosis of pembrolizumab induced myocarditis
Wu, Z., Sun, W., & Wang, C. (2025) · Investigational New Drugs · doi:10.1007/s10637-025-01575-y · Cited by 5
Animal Models: Systemic Autoimmune Diseases
Mizui, M., & Tsokos, G. C. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-812102-3.00029-4 · Cited by 5
de Boer, D., Streng, A. S., van Doorn, W. P. T. M., Vroemen, W. H. M., Bekers, O., Wodzig, W. K. W. H., & Mingels, A. M. A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-63908-2_4 · Cited by 5
The development of endometrial hyperplasia in aged PD-1-deficient female mice
Guo, G., Li, H., Cao, D., & Chen, Y. (2014) · Diagnostic Pathology · doi:10.1186/1746-1596-9-97 · Cited by 5
Hadi, N., Dwaich, K., Al-Amran, F. G., AL-Sheibani, B. I. M., & Yousif, N. (2018) · Vascular Investigation and Therapy · doi:10.4103/vit.vit_12_18 · Cited by 5
Fridman, W. H., & Teillaud, J. (2019) · médecine/sciences · doi:10.1051/medsci/2019074 · Cited by 5
Shimozaki, K., Hirata, K., Horie, S., Chida, A., Tsugaru, K., Hayashi, Y., Kawasaki, K., Miyanaga, R., Hayashi, H., Mizuno, R., et al. (2021) · Diagnostics · doi:10.3390/diagnostics11030543 · Cited by 5
What the Cardiologist Needs to Know About Cancer Immunotherapies and Complications
Frayberg, M., Yung, A., Zubiri, L., Zlotoff, D. A., & Reynolds, K. L. (2021) · Current Treatment Options in Oncology · doi:10.1007/s11864-021-00844-1 · Cited by 5
Matsumoto, T., Fukuda, K., Yoshida, T., Shimazu, K., Taguchi, D., Shinozaki, H., Seki, K., Yamanaka, T., Ootaka, M., Nanjyo, H., et al. (2021) · International Cancer Conference Journal · doi:10.1007/s13691-021-00525-8 · Cited by 6
Reinke, Y., Könemann, S., Chamling, B., Groß, S., Weitmann, K., Hoffmann, W. U., Klingel, K., Nauck, M. A., Fielitz, J., Dörr, M., et al. (2019) · International Journal of Cardiology · doi:10.1016/j.ijcard.2019.04.025 · Cited by 4
Mechanisms and Insights for the Development of Heart Failure Associated with Cancer Therapy
Fraley, C. E., Milgrom, S. A., Kondapalli, L., Taylor, M. R. G., Mestroni, L., & Miyamoto, S. D. (2021) · Children · doi:10.3390/children8090829 · Cited by 4
Yu, L., Huang, A., Wang, W., Du, R., Shen, L., & Hou, X. (2011) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-011-0476-2 · Cited by 4
Immunoadsorption in dilated cardiomyopathy
Staudt, A., & Felix, S. B. (2007) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2007.08.008 · Cited by 4
INFLUENCE OF ANTIBODIES AGAINST CTLA-4 AND PD-1 UPON QUANTITIES OF THEIR TARGET RECEPTORS
Chikileva, I. O., Shubina, I. Z., Самойленко, И. В., Karaulov, A. V., & Kiselevsky, M. V. (2019) · Medical Immunology (Russia) · doi:10.15789/1563-0625-2019-1-59-68 · Cited by 4
Cardiac Troponin I autoantibodies and their potential role in cardiac remodelling
Salbach, C., & Kaya, Z. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.09.005 · Cited by 4
Clinical Presentation of Myocarditis
Caforio, A. L. P., Marcolongo, R., Cheng, C., Baritussio, A., Tarantini, G., & Iliceto, S. (2020) · Springer eBooks · doi:10.1007/978-3-030-35276-9_2 · Cited by 4
Intracellular Cardiac Signaling Pathways Altered by Cancer Therapies
Scott, S. S., Greenlee, A. N., Schwendeman, E. J., Mohammad, S. J., Naughton, M. T., Matzko, A., Diallo, M., Stein, M., Revan, R., Zaramo, T. Z., et al. (2022) · Springer eBooks · doi:10.1007/978-3-031-08309-9_4 · Cited by 6
Cardiovascular Disease Risk Factors, Immune Checkpoints and Tregs
Shao, Y., Saaoud, F., Xu, K., Lu, Y., Jiang, X., Wang, H., & Yang, X. (2024) · Advances in biochemistry in health and disease · doi:10.1007/978-3-031-62806-1_2 · Cited by 4
Functional Effects of Autoantibodies
Waterman, S. A., Jackson, M., & Gordon, T. P. (2006) · Elsevier eBooks · doi:10.1016/b978-012595961-2/50020-2 · Cited by 4
The Key Players of Coxsackievirus-Induced Myocarditis
Pamela, J., Walic, M., & Marc, S. (2011) · InTech eBooks · doi:10.5772/20932 · Cited by 4
Innate Immunity in Experimental Autoimmune Myocarditis
Kaya, Z., & Rose, N. R. (2006) · Springer eBooks · doi:10.1007/0-387-24534-0_1 · Cited by 4
Inflammatory cardiomyopathy: current concepts regarding its diagnosis and treatment
Kuchynka, P., Paleček, T., Šimek, S., Vítková, I., Schramlová, J., Hulinska, D., Aster, V., Dostálová, G., Magage, S., Aschermann, M., et al. (2009) · Cor et Vasa · doi:10.33678/cor.2009.009 · Cited by 4
Yang, J., Wu, Q., Yang, Z., Sun, R., Zhang, K., Guo, X. N., Xu, R., & Guo, Y. (2024) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2024.102782 · Cited by 3
Mahadevan, A., Vosooghi, A., Arora, J. S., Jones, J. E., Moslehyazdi, M., & Chow, W. A. (2025) · Cancer Medicine · doi:10.1002/cam4.70846 · Cited by 3
Generation of a Monoclonal Antibody Recognizing Mouse PD-1
Qin, Y., Wang, G., Yang, J.-L., & Liu, C. (2014) · Monoclonal Antibodies in Immunodiagnosis and Immunotherapy · doi:10.1089/mab.2014.0024 · Cited by 3
Sun, N., Li, R., Deng, H., Li, Q., Deng, J., Zhu, Y., Mo, W., Guan, W., Hu, M., Liu, M., et al. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1372532 · Cited by 3
Özmen, Ö., Taşan, Ş., & Ünal, G. Ö. (2025) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20240159 · Cited by 4
Cardiovascular Risk Profile of Nivolumab Anti-cancer Therapy: A Review of Current Literature
Qureshi, Z. A., Zaheer, Z., Asghar, Z., Bakhtiar, M., Fatima, E., & Altaf, F. (2025) · American Journal of Clinical Oncology · doi:10.1097/coc.0000000000001166 · Cited by 3
State-of-the-art Review: Interventional Onco-Cardiology
Pushparaji, B., Marmagkiolis, K., Miller, C. K., Aziz, M. K., Balanescu, D. V., Donisan, T., Palaskas, N. L., Kim, P. Y., Lopez‐Mattei, J., Çilingiroğlu, M., et al. (2020) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-020-00809-x · Cited by 3
Tu, S., Trikannad, A. K., Vellanki, S., Hussain, M., Malik, N., Singh, S. R. K., Jillella, A., Obulareddy, S. J., Malapati, S. J., Bhatti, S. A., et al. (2024) · Cancers · doi:10.3390/cancers16061151 · Cited by 3
Cardiovascular toxicity with CTLA‐4 inhibitors in cancer patients: A meta‐analysis
Liu, H., Fu, L., Jin, S., Ye, X., Chen, Y., Pu, S., & Xue, Y. (2024) · Cancer Innovation · doi:10.1002/cai2.116 · Cited by 3
Choudhury, S., Schnell, M., Bühler, T., Reinke, Y., Lüdemann, J., Nießner, F., Brinkmeier, H., Herda, L. R., Staudt, A., Kroemer, H. K., et al. (2013) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24707 · Cited by 3
Immunoadsorption in patients with dilated cardiomyopathy
Herda, L. R., Felix, S. B., & Staudt, A. (2009) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(09)71826-4 · Cited by 3
Myocarditis and Dilated Cardiomyopathy
Rose, N. R., & Kaya, Z. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-384929-8.00070-8 · Cited by 5
Organ-Specific Autoimmune Myocardial Diseases
Caforio, A. L. P., Marcolongo, R., Malipiero, G., Agostini, C., Seguso, M., Gallo, N., Plebani, M., & Iliceto, S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803267-1.00002-8 · Cited by 3
IFN-γ versus IL-17: A Battle During Cardiac Autoimmunity Evolution
Kurtenbach, E., & Martinez, C. G. (2017) · InTech eBooks · doi:10.5772/66986 · Cited by 3
Eftekhar, S. P., Yazdanpanah, N., & Rezaei, N. (2021) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2021.1979396 · Cited by 3
Frontiers in Viral Diagnostics
Pauschinger, M., & Kallwellis-Opara, A. (2006) · Springer eBooks · doi:10.1007/3-540-30822-9_3 · Cited by 3
Felix, S. B. (2010) · Basic Research in Cardiology · doi:10.1007/s00395-010-0140-1 · Cited by 3
Mechanisms of autoimmune heart disease
Eriksson, U., Penninger, J. M., & Köpf, M. (2004) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2004.11.011 · Cited by 3
B cells and autoimmunity 2004: new concepts and therapeutic perspectives
Mourad, W. M., Lipsky, P. E., & Zouali, M. (2005) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.9.1.195 · Cited by 3
A step toward a unifying preclinical model of dilated cardiomyopathy
Nelson, V. L., Eadie, A. L., & Brunt, K. R. (2022) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00141.2022 · Cited by 3
Zhao, Y., Lu, Y., Fu, T., Zhang, J., & Tang, J. (2026) · Basic Research in Cardiology · doi:10.1007/s00395-025-01156-3 · Cited by 2
Zhang, B., Muhetarijiang, M., Sun, X., Wu, Y., Justin, R., Li, Z., Chen, T., Zhou, D., & Hu, X. (2026) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm43846 · Cited by 3
Huang, J., Xu, X., Jin, Y., Qiao, L. J., Yu, H., Gao, W., & Li, C. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1752354 · Cited by 2
Functional Autoantibodies in Myocardial Diseases
Vanhentenrijk, S., Augusto, S. N., Wilcox, J. D., Liu, C., & Tang, W. H. W. (2026) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2026.101636 · Cited by 3
Przeciwciała o działaniu immunomodulacyjnym w terapii nowotworów
Marciniec, M., Nowak, A. J., & Filip, A. A. (2015) · Nowotwory Journal of Oncology · doi:10.5603/njo.2015.0005 · Cited by 3
Functions and Clinical Significance of Myocardial Cell-Derived Immunoglobulins
Zhu, Z., Zhang, M., & Qiu, X. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-981-97-0511-5_9 · Cited by 2
Luo, Y., Yi, Y., Zeng, F., Lu, Z., Xu, W., Fang, H., Xu, P., Liu, A., & Zeng, Z. (2025) · Biochemistry and Cell Biology · doi:10.1139/bcb-2025-0170 · Cited by 2
Immunomodulatory and Immunoadsorptive Treatments
Staudt, A., & Felix, S. B. (2005) · Heart Failure Clinics · doi:10.1016/j.hfc.2005.06.008 · Cited by 2
Anti-PD-1 and Anti-B7-H1/PD-L1 Monoclonal Antibodies
Lipson, E. J., Taube, J. M., Chen, L., & Topalian, S. L. (2011) · Springer eBooks · doi:10.1007/978-1-61779-407-0_15 · Cited by 2
Animal Models of Autoimmune Disease
von Herrath, M., & Tsokos, G. C. (2006) · Elsevier eBooks · doi:10.1016/b978-012595961-2/50029-9 · Cited by 2
Novel Immunologic Approaches to Melanoma Treatment
Escandell, I., Martín, J. M., & Jordá, E. (2017) · Actas Dermo-Sifiliográficas · doi:10.1016/j.adengl.2017.07.001 · Cited by 5
Ryabkova, V. A., Churilov, L. P., & Shubik, Y. V. (2020) · Journal of Arrhythmology · doi:10.35336/va-2019-4-21-31 · Cited by 2
Immunomodulation and Immunoadsorption in Inflammatory Dilated Cardiomyopathy
Chamling, B., Könemann, S., Dörr, M., & Felix, S. B. (2020) · Springer eBooks · doi:10.1007/978-3-030-35276-9_15 · Cited by 2
Do Fetal Microchimeric Cells Influence Experimental Autoimmune Myocarditis?
Ribeiro, R. S. D. A., Demarque, K. C., Figueiredo, I., Ferreira, I. M. D. E. S. R., Valeriano, J. D. P., & Verícimo, M. A. (2021) · Fetal and Pediatric Pathology · doi:10.1080/15513815.2021.1994067 · Cited by 2
Immunotherapy related pericardial effusion on chest CT
Capaccione, K. M., Huang, S., Toor, Z., May, B. L., Deng, A., & Salvatore, M. M. (2021) · Clinical Imaging · doi:10.1016/j.clinimag.2021.11.029 · Cited by 2
Myocarditis and Dilated Cardiomyopathy
Kaya, Z., Raczek, P., & Rose, N. R. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-812102-3.00064-6 · Cited by 2
L-Type Ca2+ Channels and Cardiac Arrhythmias
Kuzmenkina, E. V., Salamon, S., Despang, P., & Matthes, J. (2023) · Springer eBooks · doi:10.1007/978-3-031-33588-4_10 · Cited by 2
Peripheral Tolerance of T Cells in the Mouse
Heissmeyer, V., Tanasă, B., & RAO, A. (2007) · Elsevier eBooks · doi:10.1016/b978-012369454-6/50088-1 · Cited by 2
Albakri, A. (2019) · Medical and Clinical Archives · doi:10.15761/mca.1000154 · Cited by 1
Rong, F., Ji, K., Weng, Y., & Peng, Y. (2020) · Cardiology Research and Practice · doi:10.1155/2020/8367651 · Cited by 1
Huang, D., Song, F., Zhang, W., Ma, H., Lin, X., Qin, T., & Wang, S. (2023) · International Journal of Cardiovascular Practice · doi:10.5812/intjcardiovascpract-130990 · Cited by 1
Flotillin-2 dampens T cell antigen sensitivity and functionality
Moon, S., Zhao, F., Uddin, M. N., Tucker, C. J., Karmaus, P. W. F., & Fessler, M. B. (2024) · JCI Insight · doi:10.1172/jci.insight.182328 · Cited by 1
Yang, F., Zhou, P., & Hua, H. (2025) · Science Progress · doi:10.1177/00368504251364109 · Cited by 1
Effect of organism aging on the development of anti-PD-(L)1 therapy-associated adverse events
Tsukamoto, H., Murakami, K., Miura, Y., & Komohara, Y. (2025) · Immunological Medicine · doi:10.1080/25785826.2025.2564474 · Cited by 1
Cardiac Troponin I Antibodies Induce Cardiomyocyte Damage and Alter Cell Morphology
Furkel, J., Zirkenbach, V. A., Knoll, M., Öttl, R., Rein, K., Abdollahi, A., Frey, N., Konstandin, M. H., & Kaya, Z. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262010005 · Cited by 1
Cardiovascular Complications in Lupus: Mechanistic Insights and Emerging Bioengineering Approaches
Horton, R. E., Folh, J., Tran, P. L. D. (., & Marchus, C. (2025) · Journal of Medical Devices · doi:10.1115/1.4070293 · Cited by 2
Nicotinamide prevents anti-PD1 immune checkpoint inhibitor-associated early stages of cardiotoxicity
Bai, L., Zhao, J., Dong, K., Zhao, M., Zhao, Y., Cong, Q., Wang, Y., Niu, X., Tang, J., & Bai, M. (2026) · Science China Life Sciences · doi:10.1007/s11427-025-3116-0 · Cited by 1
Autoantibody Profiling in Cardiomyopathies: Toward Immune-Guided Risk Stratification and Therapy
Marmai, A., Civieri, G., Iop, L., Martini, M., Vadori, M., Cozzi, E., & Tona, F. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15072615 · Cited by 1
Liu, M., 许晨晨, & 董波 (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1767098 · Cited by 1
Mincu, R. I., Zimmer, L., Vlachopoulou, D., Haj‐Yehia, E., Hoffmann, J., Michel, L., Livingstone, E., Schadendorf, D., Tasdogan, A., Totzeck, M., et al. (2026) · British Journal of Pharmacology · doi:10.1111/bph.70536 · Cited by 1
Metadata
- Authors
- Okazaki, T., Tanaka, Y., Nishio, R., Mitsuiye, T., Mizoguchi, A., Wang, J., Ishida, M., Hiai, H., Matsumori, A., Minato, N., & Honjo, T.
- Affiliations
- Kyoto University (JP)
- Mie University (JP)
- Corresponding author
- Honjo, Tasuku
- ORCID
- Venue
- Nature Medicine
- Published
- 2003-11-02
- Volume
- 9
- Issue
- 12
- Pages
- 1477-1483
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2140419562
- Semantic Scholar
- 8b8bf12ad1a303d244e325c58410b356c4ed2945
- Cited by
- 689
- References
- 38
- Citations by year
- 2026: 24 · 2025: 30 · 2024: 44 · 2023: 36 · 2022: 49 · 2021: 49 · 2020: 47 · 2019: 46 · 2018: 28 · 2017: 30 · 2016: 32 · 2015: 19 · 2014: 20 · 2013: 22 · 2012: 16
- FWCI
- 16.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Keywords
- cardiac troponin I, autoantibodies, dilated cardiomyopathy, PD-1 deficiency, autoimmune cardiomyopathy, familial hypertrophic cardiomyopathy, L-type calcium current, cardiac dysfunction, monoclonal antibodies
- MeSH terms
- Animals, Antibodies, Monoclonal, Antigens, Surface, Autoantibodies, Base Sequence, Cardiomyopathy, Dilated, Humans, Mice, Inbred A, Mice, Inbred BALB C, Mice, Nude, Antigens, CD, Rats, Wistar, DNA, Complementary, Mice, Knockout, Troponin I, Calcium Signaling, Myocytes, Cardiac, Apoptosis Regulatory Proteins, Mice, Rats, Programmed Cell Death 1 Receptor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.